Though upregulation of CXCL13 was implicated in the development of autoimmune insulitis in mice 35, we observed no difference in serum CXCL13 levels between ESRD patients with (primarily IDDM) and without a history of clinical autoimmunity. Here, CXCL13 is linked to type 1 diabetes mellitus.